Albumin Market - Global Industry Analysis

Albumin Market By Product (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), By Application (Therapeutics, Diagnostics, Drug Delivery, Vaccine Ingredient, Culture Medium Ingredient & Stabilizer, In-Vitro Fertilization, and Others), By End-User (Pharmaceutical & Biotechnology Industry, Research Institutes, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 15-Jun-2022 Category: Pharmaceutical Report Format : PDF Pages: 190 Report Code: ZMR-3434 Status : Published

The global albumin market was at a market value of $4.2B in 2021 and is projected to reach the global market value of $9B by 2028 at a CAGR of 6.5% during the forecast period.

Description

Industry Prospective:

The global albumin market was at a market value of $4.2B in 2021 and is projected to reach the global market value of $9B by 2028 at a CAGR of 6.5% during the forecast period. The report analyzes the albumin market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global albumin market.

Albumin Market: Overview

Albumin is a family of water-soluble globular proteins found in the human body. Albumin is created in the body by the liver, lower levels of which indicate liver or kidney problems.

Albumin is a carrier of other important components like enzymes, vitamins, and hormones throughout the body and helps in volumizing blood flow. It is used in the treatment of a variety of diseases including diabetes, cancer, trauma, renal dialysis, liver diseases, acute respiratory distress, nephrosis, and hepatitis.

Covid-19 Impact:

Covid-19 had a positive impact on the global albumin market because of the high demands for vaccines like AstraZeneca (Covishield) and Covaxin. The global market is projected to show steady growth during the forecast period owing to the multi-purpose benefits and use of albumin protein in healthcare.

Global Albumin Market

Albumin Market: Growth Drivers

Rise in rare medical cases along with non-therapeutic use of Albumin to propel global market growth

With advancements in technology, the detection of rare diseases which can be effectively treated with albumin has increased. This is projected to instill a rise in the global market value of albumin.

Extensive use of albumin in vaccine preparation is expected to boost the global market during the forecast period. The growing awareness of recombinant albumin products & their benefits is expected to become a chief global market driver during the projection period.

Furthermore, the rise in competition and subsequent expansion of companies in the global market is expected to push the global market growth.

Albumin Market: Restraints

Irrational usage and adverse reactions related to albumin to restraint global market growth

An increase in the irrational use of albumin is anticipated to restrain the global albumin market growth during the forecast period. Irrational use includes hypoproteinemia and nutritional support. This is caused by a non-essential or unsuitable prescription of albumin. Adverse reactions like ankle & leg swelling, itching or skin rash, breathing difficulties, and discoloration of lips & fingertips due to albumin-related products are anticipated to restrain the global market growth.

Increase in preference for serum-free solutions to cause a glitch in global market growth

The global market is witnessing a rise in demand for serum-free solutions given the lesser risk of contamination in serum-free solutions along with easier purification. The shift in preference is anticipated to act as a restraining agent in the global market.

Albumin Market: Opportunities

Potential untapped market and cost-effective large scale production to provide growth opportunities to the global market

A lot of undeveloped or developing economies have a tremendous amount of untapped potential in the global market. This provides a great opportunity for market leaders to explore. World leaders have started investing in large-scale production which can reduce expenses making the global market cost-effective and providing for more opportunities in the global market.

Increasing awareness of better health to bring growth opportunities in the global market

There has been a rising awareness amongst the general population for better health. This has ultimately emphasized the drug development process. The rise in drug demands is anticipated to provide growth opportunities in the global market during the forecast period.

Albumin Market: Challenges

Government regulations and substitute products pose challenges to the global market growth

There are several government regulations laid down by every country. These regulations hamper the smooth development and distribution of albumin creating unfavorable conditions for the global market growth. There has been an increase in the development of substitutes like sodium chloride solutions for albumin. The rise in alternatives to albumin poses a major challenge in the global albumin market.

Supplier’s bargaining power and increasing competition to create challenging situations in the global market

With the rise in demand for albumin, there has been a significant shift in the bargaining power of the suppliers. Additionally, the global competition has been increasing tremendously which is projected to create challenging situations in the global market.

Albumin Market: Segmentation

The global albumin market is segmented by product, application, end-user, and region.

Based on product, the global market is segmented into human serum albumin, bovine serum albumin, and recombinant albumin. The most widely used albumin products are human serum albumin and bovine serum albumin. They are expected to continue the growing trend during the forecast period because of their rich compositions and cost-effectiveness.

Based on application, the global market is segmented into therapeutics, diagnostics, drug delivery, vaccine ingredient, culture medium, ingredient & stabilizer, and in-vitro fertilization. The market share for vaccine ingredients is projected to grow extensively during the forecast period.

Based on end-user, the global market is segmented into the pharmaceutical & biotechnology industry and research institutes. Both the industries are projected to contribute significantly to the global market in response to rising consumer drug demand and the need for detailed research in the field.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Recent Developments:

  • In March 2020, FDA approved the use of the Pumotech MAA kit to Curium Pharma. The kit is used to prepare technetium Tc 99m Albumin aggregated injection. The injection is used for lung imaging and evaluation of pulmonary perfusion. The injection acts as a single-photon emission agent.
  • May 2020 witnessed the announcement by Bio Products Laboratory for the US launch of Albuminex 5% and Albuminex 25% solutions to be used for injection. The injection is FDA approved and is used in treatment related to burns, cardiopulmonary bypass, acute nephrosis, and ARDS.

Albumin Market: Regional Landscape

The unexplored market size of Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period owing to increasing demand for vaccines and heavy investments in the healthcare sector. This is followed by Europe and North America because of greater awareness and acceptance of the drugs. These regions have a high per capita capacity for medical expenditure and are expected to carry the same growing trend in the global market during the projection period.

The Middle East has been showing steady signs of market growth caused by rising health awareness amongst the consumer group and better healthcare policies. Africa is projected to grow relatively slower because of poor infrastructure and lack of research or treatment facilities. The slow economic growth along with restricted access to resources is also a contributing factor to the slow development during the forecast period.

Albumin Market: Competitive Landscape:

The global albumin market includes key competitors like Baxter International Inc., Akron Biotech, Octapharma AG, HiMedia Laboratories Pvt. Ltd.Grifols, SA, Takeda Pharmaceuticals Inc, Mitsubishi Tanabe Pharma Corporation, Merck KGaA, Thermo Fisher Scientific Inc., China Biologic Products, Inc, Sigma-Aldrich Co. LLC., Novozymes, CSL Limited, Ventria Bioscience, Medxbio Pte Ltd.

The global albumin market is segmented as follows:

By product:

  •  Human serum albumin
  •  Bovine serum albumin
  •  Recombinant albumin

By application:

  • Therapeutics
  • Diagnostics
  • Drug delivery
  • Vaccine ingredient
  • Culture medium
  • Ingredient & stabilizer
  • In-vitro fertilization

By end-user

  • Pharmaceutical & biotechnology industry
  •  Research institutes

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Albumin Market, (2022 - 2028) (USD 9.00 Billion)
    • 2.2 Global Albumin Market : snapshot
  • Chapter 3. Global Albumin Market - Industry Analysis
    • 3.1 Albumin Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Rise in rare medical cases along with non-therapeutic use of Albumin to propel global market growth
    • 3.3 Market Restraints
      • 3.3.1. Irrational usage and adverse reactions related to albumin to restraint global market growth
    • 3.4 Market Opportunities
      • 3.4.1. Potential untapped market and cost-effective large scale production to provide growth opportunities to the global market
    • 3.5 Market Challenges
      • 3.5.1. Government regulations and substitute products pose challenges to the global market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By product
      • 3.7.2 Market attractiveness analysis By application
      • 3.7.3 Market attractiveness analysis By end-user
  • Chapter 4. Global Albumin Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Albumin Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Albumin Market - product Analysis
    • 5.1 Global Albumin Market overview: By product
      • 5.1.1 Global Albumin Market share, By product, 2021 and 2028
    • 5.2 Human serum albumin
      • 5.2.1 Global Albumin Market by Human serum albumin, 2022 - 2028 (USD 9.00 Billion)
    • 5.3 Bovine serum albumin
      • 5.3.1 Global Albumin Market by Bovine serum albumin, 2022 - 2028 (USD 9.00 Billion)
    • 5.4 Recombinant albumin
      • 5.4.1 Global Albumin Market by Recombinant albumin, 2022 - 2028 (USD 9.00 Billion)
  • Chapter 6. Global Albumin Market - application Analysis
    • 6.1 Global Albumin Market overview: By application
      • 6.1.1 Global Albumin Market share, By application, 2021 and 2028
    • 6.2 Therapeutics
      • 6.2.1 Global Albumin Market by Therapeutics, 2022 - 2028 (USD 9.00 Billion)
    • 6.3 Diagnostics
      • 6.3.1 Global Albumin Market by Diagnostics, 2022 - 2028 (USD 9.00 Billion)
    • 6.4 Drug delivery
      • 6.4.1 Global Albumin Market by Drug delivery, 2022 - 2028 (USD 9.00 Billion)
    • 6.5 Vaccine ingredient
      • 6.5.1 Global Albumin Market by Vaccine ingredient, 2022 - 2028 (USD 9.00 Billion)
    • 6.6 Culture medium
      • 6.6.1 Global Albumin Market by Culture medium, 2022 - 2028 (USD 9.00 Billion)
    • 6.7 Ingredient & stabilizer
      • 6.7.1 Global Albumin Market by Ingredient & stabilizer, 2022 - 2028 (USD 9.00 Billion)
    • 6.8 In-vitro fertilization
      • 6.8.1 Global Albumin Market by In-vitro fertilization, 2022 - 2028 (USD 9.00 Billion)
    • 6.9 In-vitro fertilization
      • 6.9.1 Global Albumin Market by In-vitro fertilization, 2022 - 2028 (USD 9.00 Billion)
  • Chapter 7. Global Albumin Market - end-user Analysis
    • 7.1 Global Albumin Market overview: By end-user
      • 7.1.1 Global Albumin Market share, By end-user, 2021 and 2028
    • 7.2 Pharmaceutical & biotechnology industry
      • 7.2.1 Global Albumin Market by Pharmaceutical & biotechnology industry, 2022 - 2028 (USD 9.00 Billion)
    • 7.3 Research institutes
      • 7.3.1 Global Albumin Market by Research institutes, 2022 - 2028 (USD 9.00 Billion)
  • Chapter 8. Albumin Market - Regional Analysis
    • 8.1 Global Albumin Market Regional Overview
    • 8.2 Global Albumin Market Share, by Region, 2021 & 2028 (USD 9.00 Billion)
    • 8.3. North America
      • 8.3.1 North America Albumin Market, 2022 - 2028 (USD 9.00 Billion)
        • 8.3.1.1 North America Albumin Market, by Country, 2022 - 2028 (USD 9.00 Billion)
    • 8.4 North America Albumin Market, by product, 2022 - 2028
      • 8.4.1 North America Albumin Market, by product, 2022 - 2028 (USD 9.00 Billion)
    • 8.5 North America Albumin Market, by application, 2022 - 2028
      • 8.5.1 North America Albumin Market, by application, 2022 - 2028 (USD 9.00 Billion)
    • 8.6 North America Albumin Market, by end-user, 2022 - 2028
      • 8.6.1 North America Albumin Market, by end-user, 2022 - 2028 (USD 9.00 Billion)
    • 8.4. Europe
      • 8.4.2 Europe Albumin Market, 2022 - 2028 (USD 9.00 Billion)
        • 8.4.2.1 Europe Albumin Market, by Country, 2022 - 2028 (USD 9.00 Billion)
    • 8.4 Europe Albumin Market, by product, 2022 - 2028
      • 8.4.1 Europe Albumin Market, by product, 2022 - 2028 (USD 9.00 Billion)
    • 8.5 Europe Albumin Market, by application, 2022 - 2028
      • 8.5.1 Europe Albumin Market, by application, 2022 - 2028 (USD 9.00 Billion)
    • 8.6 Europe Albumin Market, by end-user, 2022 - 2028
      • 8.6.1 Europe Albumin Market, by end-user, 2022 - 2028 (USD 9.00 Billion)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Albumin Market, 2022 - 2028 (USD 9.00 Billion)
        • 8.5.3.1 Asia Pacific Albumin Market, by Country, 2022 - 2028 (USD 9.00 Billion)
    • 8.4 Asia Pacific Albumin Market, by product, 2022 - 2028
      • 8.4.1 Asia Pacific Albumin Market, by product, 2022 - 2028 (USD 9.00 Billion)
    • 8.5 Asia Pacific Albumin Market, by application, 2022 - 2028
      • 8.5.1 Asia Pacific Albumin Market, by application, 2022 - 2028 (USD 9.00 Billion)
    • 8.6 Asia Pacific Albumin Market, by end-user, 2022 - 2028
      • 8.6.1 Asia Pacific Albumin Market, by end-user, 2022 - 2028 (USD 9.00 Billion)
    • 8.6. Latin America
      • 8.6.4 Latin America Albumin Market, 2022 - 2028 (USD 9.00 Billion)
        • 8.6.4.1 Latin America Albumin Market, by Country, 2022 - 2028 (USD 9.00 Billion)
    • 8.4 Latin America Albumin Market, by product, 2022 - 2028
      • 8.4.1 Latin America Albumin Market, by product, 2022 - 2028 (USD 9.00 Billion)
    • 8.5 Latin America Albumin Market, by application, 2022 - 2028
      • 8.5.1 Latin America Albumin Market, by application, 2022 - 2028 (USD 9.00 Billion)
    • 8.6 Latin America Albumin Market, by end-user, 2022 - 2028
      • 8.6.1 Latin America Albumin Market, by end-user, 2022 - 2028 (USD 9.00 Billion)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Albumin Market, 2022 - 2028 (USD 9.00 Billion)
        • 8.7.5.1 The Middle-East and Africa Albumin Market, by Country, 2022 - 2028 (USD 9.00 Billion)
    • 8.4 The Middle-East and Africa Albumin Market, by product, 2022 - 2028
      • 8.4.1 The Middle-East and Africa Albumin Market, by product, 2022 - 2028 (USD 9.00 Billion)
    • 8.5 The Middle-East and Africa Albumin Market, by application, 2022 - 2028
      • 8.5.1 The Middle-East and Africa Albumin Market, by application, 2022 - 2028 (USD 9.00 Billion)
    • 8.6 The Middle-East and Africa Albumin Market, by end-user, 2022 - 2028
      • 8.6.1 The Middle-East and Africa Albumin Market, by end-user, 2022 - 2028 (USD 9.00 Billion)
  • Chapter 9. Company Profiles
    • 9.1 Baxter International Inc.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 Akron Biotech
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Octapharma AG
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 HiMedia Laboratories Pvt. Ltd.
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Grifols SA
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Takeda Pharmaceuticals Inc
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Mitsubishi Tanabe Pharma Corporation
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Merck KGaA
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Thermo Fisher Scientific Inc.
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 China Biologic Products Inc
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments
    • 9.11 Sigma-Aldrich Co. LLC.
      • 9.11.1 Overview
      • 9.11.2 Financials
      • 9.11.3 Product Portfolio
      • 9.11.4 Business Strategy
      • 9.11.5 Recent Developments
    • 9.12 Novozymes
      • 9.12.1 Overview
      • 9.12.2 Financials
      • 9.12.3 Product Portfolio
      • 9.12.4 Business Strategy
      • 9.12.5 Recent Developments
    • 9.13 CSL Limited
      • 9.13.1 Overview
      • 9.13.2 Financials
      • 9.13.3 Product Portfolio
      • 9.13.4 Business Strategy
      • 9.13.5 Recent Developments
    • 9.14 Ventria Bioscience
      • 9.14.1 Overview
      • 9.14.2 Financials
      • 9.14.3 Product Portfolio
      • 9.14.4 Business Strategy
      • 9.14.5 Recent Developments
    • 9.15 Medxbio Pte Ltd.
      • 9.15.1 Overview
      • 9.15.2 Financials
      • 9.15.3 Product Portfolio
      • 9.15.4 Business Strategy
      • 9.15.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Albumin Market, 2022 - 2028 (USD 9.00 Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Albumin Market attractiveness, By product
  • 6. Global Albumin Market attractiveness, By application
  • 7. Global Albumin Market attractiveness, By end-user
  • 8. Global Albumin Market share by product, 2022 and 2028 (USD 9.00 Billion)
  • 9. Global Albumin Market by Human serum albumin, 2022 - 2028 (USD 9.00 Billion)
  • 10. Global Albumin Market by Bovine serum albumin, 2022 - 2028 (USD 9.00 Billion)
  • 11. Global Albumin Market by Recombinant albumin, 2022 - 2028 (USD 9.00 Billion)
  • 12. Global Albumin Market share by application, 2022 and 2028 (USD 9.00 Billion)
  • 13. Global Albumin Market by Therapeutics, 2022 - 2028 (USD 9.00 Billion)
  • 14. Global Albumin Market by Diagnostics, 2022 - 2028 (USD 9.00 Billion)
  • 15. Global Albumin Market by Drug delivery, 2022 - 2028 (USD 9.00 Billion)
  • 16. Global Albumin Market by Vaccine ingredient, 2022 - 2028 (USD 9.00 Billion)
  • 17. Global Albumin Market by Culture medium, 2022 - 2028 (USD 9.00 Billion)
  • 18. Global Albumin Market by Ingredient & stabilizer, 2022 - 2028 (USD 9.00 Billion)
  • 19. Global Albumin Market by In-vitro fertilization, 2022 - 2028 (USD 9.00 Billion)
  • 20. Global Albumin Market by In-vitro fertilization, 2022 - 2028 (USD 9.00 Billion)
  • 21. Global Albumin Market share by end-user, 2022 and 2028 (USD 9.00 Billion)
  • 22. Global Albumin Market by Pharmaceutical & biotechnology industry, 2022 - 2028 (USD 9.00 Billion)
  • 23. Global Albumin Market by Research institutes, 2022 - 2028 (USD 9.00 Billion)
  • 24. Global Albumin Market share, by Region, 2022 and 2028
  • 25. North America Albumin Market, 2022 - 2028 (USD 9.00 Billion)
  • 26. Europe Albumin Market, 2022 - 2028 (USD 9.00 Billion)
  • 27. Asia Pacific Albumin Market, 2022 - 2028 (USD 9.00 Billion)
  • 28. Latin America Albumin Market, 2022 - 2028 (USD 9.00 Billion)
  • 29. The Middle-East and Africa Albumin Market, 2022 - 2028 (USD 9.00 Billion)

Table Of Tables

  • 1. Global Albumin Market: Snapshot
  • 2. Drivers of the Albumin Market: impact analysis
  • 3. North America Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 4. North America Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 5. North America Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 6. U.S. Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 7. U.S. Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 8. U.S. Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 9. Canada Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 10. Canada Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 11. Canada Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 12. Europe Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 13. Europe Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 14. Europe Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 15. Germany Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 16. Germany Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 17. Germany Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 18. France Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 19. France Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 20. France Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 21. U.K. Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 22. U.K. Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 23. U.K. Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 24. Italy Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 25. Italy Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 26. Italy Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 27. Spain Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 28. Spain Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 29. Spain Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 30. Rest of Europe Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 31. Rest of Europe Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 32. Rest of Europe Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 33. Asia Pacific Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 34. Asia Pacific Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 35. Asia Pacific Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 36. China Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 37. China Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 38. China Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 39. Japan Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 40. Japan Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 41. Japan Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 42. India Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 43. India Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 44. India Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 45. South Korea Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 46. South Korea Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 47. South Korea Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 48. South-East Asia Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 49. South-East Asia Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 50. South-East Asia Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 51. Rest of Asia Pacific Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 52. Rest of Asia Pacific Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 53. Rest of Asia Pacific Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 54. Latin America Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 55. Latin America Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 56. Latin America Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 57. Brazil Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 58. Brazil Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 59. Brazil Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 60. Mexico Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 61. Mexico Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 62. Mexico Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 63. Rest of Latin America Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 64. Rest of Latin America Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 65. Rest of Latin America Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 66. The Middle-East and Africa Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 67. The Middle-East and Africa Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 68. The Middle-East and Africa Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 69. GCC Countries Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 70. GCC Countries Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 71. GCC Countries Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 72. South Africa Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 73. South Africa Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 74. South Africa Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)
  • 75. Rest of Middle-East Africa Albumin Market revenue, By product, 2022 - 2028 (USD 9.00 Billion)
  • 76. Rest of Middle-East Africa Albumin Market revenue, By application, 2022 - 2028 (USD 9.00 Billion)
  • 77. Rest of Middle-East Africa Albumin Market revenue, By end-user, 2022 - 2028 (USD 9.00 Billion)

Methodology

Free Analysis

Albumin is a type of protein found abundantly in the blood plasma. Albumin performs diverse kinds of functions, such as transporting fatty acids and hormones and maintaining the pressure. It also helps in restoring blood volume after surgeries, burns, infections, trauma, and in liver diseases and is used to replace lost fluid. It is also used in surface absorption and to stabilize drugs by lowering aggregation. Different kinds of serum albumin are extensively used in different clinical applications. 

In the Asia Pacific region, there are various awareness programs conducted by organizations, such as PPTA, to increase the awareness about plasma donation and the various plasma protein therapies available. The rising awareness and supportive activities by government and various organizations to increase awareness about the use of albumin are among the main factors fueling the growth of the global albumin market. The rise in applications of albumin in various fields, such as vaccines, media preparation, drug delivery, etc. is also fueling the growth of the global albumin market. The rise in the prevalence of diseases leading to hypoalbuminemia, increase in demand for albumin in non-therapeutic industry, the rise in demand for albumin in research and development, and rise in production of immunoglobin are some of the other factors driving the growth of the global albumin market.

Global Albumin Market

Albumin market can be categorized on the basis of application, product type, and end-user. On the basis of product type, the albumin market is segregated into recombinant albumin, bovine serum albumin, and human serum albumin. Human serum albumin segment is projected to lead the albumin market in the upcoming years. On the basis of application, the albumin market is segmented into therapeutics and diagnostics, drug delivery, vaccine ingredient, culture medium ingredient & stabilizer, in-vitro fertilization, and others. Drug delivery segment is anticipated to grow at a higher rate compared to other sub-segments. The end-user segment includes pharmaceutical & biotechnology industries, research institutes, and others. Pharmaceutical & biotechnology industries are expected to dominate the end-user segment of the global albumin market.

In terms of revenue share, Asia Pacific is expected to lead the albumin market in the upcoming years. Increase in the use of albumin for treatment of various diseases, increase in research and development activities, and increase in awareness about the therapeutic application of immunoglobin are some of the factors driving the albumin market in this region. North America is the second lucrative market for albumin, owing to the developed biotechnological industry, use of technologically developed procedures in R&D, and rise in the application of albumin in different clinical situations.

The main players in the global albumin market are Behring LLC, HiMedia Laboratories Pvt. Ltd., Albumedix A/S, Grifols International S.A., Albumin Therapeutics, LLC, InVitria, RayBiotech, Inc., Octapharma AG, Sigma-Aldrich Co., and SeraCare Life Sciences. The major companies focus on setting-up new manufacturing units to increase their production capacity. For instance, in September 2017, InVitria announced its expansion of laboratory facility to double its production capacity of recombinant proteins.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Rising cases of rare medical diseases are projected to propel the global market growth. Non-therapeutic use of albumin is also predicted to influence the global market growth along with the increase in the number of companies exploring the global market. Increasing albumin demand for R&D purposes is anticipated to become a major global market propeller.

According to Zion Market Research, the global albumin market was at a market value of $4.2B in 2021 and is projected to reach the global market value of $9B by 2028 at a CAGR of 6.5% during the forecast period.

Asia-Pacific is expected to garner the highest market share during the forecast period owing to increased albumin demand in regions like China and India. This is followed by North America and Europe caused by heavy investments in healthcare, R&D, and innovation in the pharmaceutical industry. The Middle East is expected to show steady growth in the global market. It is followed by Africa with slow anticipated growth owing to unrushed economic growth and less availability of treatment & research facilities.

The global albumin market includes key competitors like Baxter International Inc., Akron Biotech, Octapharma AG, HiMedia Laboratories Pvt. Ltd.Grifols, SA, Takeda Pharmaceuticals Inc, Mitsubishi Tanabe Pharma Corporation, Merck KGaA, Thermo Fisher Scientific Inc., China Biologic Products, Inc, Sigma-Aldrich Co. LLC., Novozymes, CSL Limited, Ventria Bioscience, Medxbio Pte Ltd.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed